{"id":110719,"date":"2024-07-10T00:00:00","date_gmt":"2024-07-10T00:00:00","guid":{"rendered":"https:\/\/medgoo.com\/index.php\/2024\/07\/10\/nirsevimab-effective-against-rsv-linked-bronchiolitis-hospitalization\/"},"modified":"2024-07-11T20:05:39","modified_gmt":"2024-07-11T20:05:39","slug":"nirsevimab-effective-against-rsv-linked-bronchiolitis-hospitalization","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2024\/07\/10\/nirsevimab-effective-against-rsv-linked-bronchiolitis-hospitalization\/","title":{"rendered":"Nirsevimab Effective Against RSV-Linked Bronchiolitis Hospitalization"},"content":{"rendered":"<h3>\n<p>Nirsevimab therapy also effective against RSV-linked bronchiolitis resulting in critical care, ventilatory support for infants<\/p>\n<\/h3>\n<p><b>By Elana Gotkine HealthDay Reporter<\/b><\/p>\n<p><b><\/b><\/p>\n<p>WEDNESDAY, July 10, 2024 (HealthDay News) &#8212; Nirsevimab therapy is effective for reducing the risk for hospitalization for respiratory syncytial virus (RSV)-associated bronchiolitis among infants, according to a study published in the July 11 issue of the <em>New England Journal of Medicine<\/em>.<\/p>\n<p>Zein Assad, M.D., from the Robert Debr \u00a9 University Hospital in Paris, and colleagues conducted a prospective, multicenter, matched case-control study to analyze the effectiveness of nirsevimab therapy against hospitalization for RSV-associated bronchiolitis in infants. Case patients were infants younger than 12 months of age who were hospitalized for RSV-associated bronchiolitis. Control patients were infants with clinical visits for conditions unrelated to RSV infection. The study included 1,035 infants: 690 case patients and 345 controls matched on the basis of age, date of hospital visit, and study center.<\/p>\n<p>Overall, 60 and 97 case and control patients, respectively, had received nirsevimab previously. The researchers found that the estimated adjusted effectiveness of nirsevimab therapy was 83.0 percent against hospitalization for RSV-associated bronchiolitis. Similar results were seen in a sensitivity analysis as those in the primary analysis. The effectiveness of nirsevimab therapy was 69.6 and 67.2 percent against RSV-associated bronchiolitis resulting in critical care and against RSV-associated bronchiolitis resulting in ventilatory support, respectively.<\/p>\n<p>&#8220;Nirsevimab prophylaxis was effective against RSV-associated bronchiolitis leading to hospitalization among infants younger than 12 months of age, including those with severe cases that led to pediatric intensive care unit admission and ventilatory support,&#8221; the authors write.<\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2314885\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2024 <a href=\"https:\/\/consumer.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nirsevimab therapy also effective against RSV-linked bronchiolitis resulting in critical care, ventilatory support for infants<\/p>\n","protected":false},"author":6,"featured_media":110786,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-110719","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/110719","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=110719"}],"version-history":[{"count":1,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/110719\/revisions"}],"predecessor-version":[{"id":110785,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/110719\/revisions\/110785"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/110786"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=110719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=110719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=110719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}